Biotech stocks fell Friday, a day after the U.S. Food and Drug Administration made its database of side effects for medicines searchable. Sarepta Therapeutics, Ionis Pharmaceuticals, Biogen and Acadia Pharmaceuticals all traded lower Friday morning as investors turned up reports on their medicines on the FDA’s Adverse Events Reporting System. The problem? It’s not clear […]
Read moreThe pressure big U.S. tech companies are now starting to feel might be just the beginning. “The gross idolatry, or mother-of-all hall passes that big tech has received from government and from regulators is coming to an end,” NYU Stern School of Business professor Scott Galloway told CNBC’s “Squawk Alley” Friday. Members of Congress said […]
Read moreWith a budget of $100,000, you can run an effective campaign on Facebook no matter if your goals are to reach a mass audience or a smaller, specific group of people according to media buyers. Facebook said in early September Russian operatives spent $100,000 on ads with “divisive messages,” which seemed to be aimed at […]
Read moreHere’s a roundup of the most important deals in venture capital this week. Start-ups funded London-based Deliveroo, a food delivery service (reminiscent of Grubhub in the U.S.) has raised $385 million in growth funding from T. Rowe Price, Fidelity and earlier backers like Index Ventures. As the Financial Times reported, Deliveroo has been widely criticized […]
Read moreRyanair issued a statement Friday informing passengers about their right to compensation for thousands of canceled flights as the budget airline faced the threat of legal action over allegedly misleading statements made so far. The move came after the Britain’s Civil Aviation Authority (CAA) gave the budget airline gave Ryanair until 4 p.m. GMT (12 […]
Read moreAs U.S. stocks continue to grind higher, closely followed strategist Jeff Saut told CNBC on Friday that the current bull market likely has about six to eight years left to run. “Secular bull markets have three legs. The first leg ended in May of 2015,” said Saut, chief investment strategist at Raymond James. “We started […]
Read moreCNBC’s Jim Cramer said Friday that Wall Street is witnessing the best bull market in homebuilders that he can “ever recall” but Congress is “fooling around” with it. After the bell Thursday, homebuilder KB Home beat Wall Street’s quarterly earnings and revenue estimates and saw average selling prices rise by 12 percent, with profit margins […]
Read moreKaitlyn Johnson, a seven-year-old from outside Dallas who loves cheerleading, her science classes, and the color pink, and Justin Pritikin, a 17-year-old high school senior in New Jersey looking forward to starting college, have never met. But they’ve got one important thing in common: they were both among the courageous participants in clinical trials of […]
Read moreTreasury yields rose suddenly on reports that Kevin Warsh, a former Fed governor, met with President Donald Trump Thursday to discuss his potential nomination as Fed chair. Warsh has increasingly been seen as a leading candidate to replace Fed Chair Janet Yellen and bond traders view him as a hawkish choice. The PredictIt probability market […]
Read moreSeptember has historically been the least volatile month of the year, but volatility this September is the lowest it’s ever been, says LPL Financial’s Ryan Detrick. “So far this year, 40 basis points is the average intraday move that we’ve seen so far on the S&P 500 this September, which is the least volatile ever,” […]
Read more